Scholar IQ
Try ScholarIQ free
Upload Records Snowball Search Search OpenAlex
About the database
ScholarIQanswers from OpenAlex

Immunomodulatory drug CC-5013 overcomes drug resistance and is well tolerated in patients with relapsed multiple myeloma

PaperCitations, authors & open-access status

Immunomodulatory drug CC-5013 overcomes drug resistance and is well tolerated in patients with relapsed multiple myeloma is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 805 citations, 2002 year and bronze oa status.

805
Citations
2002
Year
bronze
OA Status

Related on ScholarIQ

Edie Weller
Author
Blood
Journal
Multiple Myeloma Research and Treatments
Topic
Multiple Myeloma Research and Treatments
Topic
Cancer Treatment and Pharmacology
Topic
Cancer therapeutics and mechanisms
Topic
470M+ articles · free account